SOURCE: PHT Corporation

March 26, 2008 09:00 ET

PHT Launches SitePad™ Tablet to Clinical Research Industry With Worldwide Virtual Launch on March 28

Webinar Offers CEO Insights, Live Product Demo, Chance to Win a Samsung UMPC

BOSTON, MA--(Marketwire - March 26, 2008) - PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 345 clinical trials worldwide, will host an informative webinar to launch its revolutionary SitePad™ Tablet on Friday, March 28, 2008 from 11am-12pm (Eastern). Registration is online at: www.regonline.com/tablet.

PHT's SitePad™ Tablet is a breakthrough technology that will forever change the quality of site-based ePRO data capture worldwide. The complimentary virtual launch will feature an introduction by President and CEO Phil Lee and an exclusive product demonstration by Sheila Rocchio, Vice President of Marketing. Interactive questions will be entertained at the close of the presentation, and one attendee will win a Samsung Q1 Ultra Mobile PC.

All are welcome to attend the virtual launch by registering at: www.regonline.com/tablet.

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 345 clinical trials by 90 biopharmaceutical clients around the world. The company's proven LogPad® and StudyPad® Systems deliver the voice of the patient -- directly and without distortion -- with reliable and timely self-reported data. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least nine NDA submissions, with five known approvals, to date. To learn more about how study sponsors worldwide are using ePRO to improve data quality, conduct smaller trials, and manage patient safety, enrollment and compliance in real time, visit www.phtcorp.com.

PHT, LogPad and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information

  • Media Contact:
    Brenda Nashawaty
    PHT Corporation
    617-688-3253
    Email Contact